Fecal microbiota transplant by push enteroscopy to treat diarrhea caused by Clostridium difficile.

Autor: Ganc AJ; Universidade Federal de São Paulo, São Paulo, SP, Brazil., Ganc RL; Hospital Israelita Albert Einstein, São Paulo, SP, Brazil., Reimão SM; Universidade de São Paulo, São Paulo, SP, Brazil., Frisoli Junior A; Universidade Federal de São Paulo, São Paulo, SP, Brazil., Pasternak J; Hospital Israelita Albert Einstein, São Paulo, SP, Brazil.
Jazyk: English; Portuguese
Zdroj: Einstein (Sao Paulo, Brazil) [Einstein (Sao Paulo)] 2015 Apr-Jun; Vol. 13 (2), pp. 338-9.
DOI: 10.1590/S1679-45082015MD3106
Abstrakt: Clostridium difficile is the major etiological agent of pseudomembranous colitis and is found in up to 20% of adult inpatients. The recommended treatment is antibiotic therapy with metronidazole and/or vancomycin. However, the recurrence rate may reach up to 25% and it increases in each episode. The newest alternative to treat diarrhea due to recurrent Clostridium difficile is fecal microbiota transplantation. The procedure was performed in 12 patients, with a 6-month follow-up on 10 of them. Of the ten cases, bacterial recurrence was diagnosed in only one patient, after a course of antibiotic to treat urinary tract infection, without presenting with diarrhea. The particularity of our study, besides being an unprecedented event in South America, is the way to perform the infusion of fecal microbiota by enteroscopy.
Databáze: MEDLINE